医学
银屑病
皮肤病科
溃疡性结肠炎
疾病
人口
糖尿病
白癜风
维生素D与神经学
炎症性肠病
内科学
内分泌学
环境卫生
作者
Karl T Clebak,Leesha Helm,Galen Foulke,Matthew F. Helm
出处
期刊:PubMed
[National Institutes of Health]
日期:2023-03-01
卷期号:526: 7-12
被引量:2
摘要
Psoriasis is a chronic, inflammatory skin condition with significant effect on quality of life. It affects 3.2% of the United States population. Psoriasis is caused by an interaction between genetic and environmental triggers. Associated conditions include depression, increased cardiovascular risk, hypertension, hyperlipidemia, diabetes, nonalcoholic fatty liver disease, Crohn disease, ulcerative colitis, celiac disease, nonmelanoma skin cancers, and lymphoma. Several clinical variants exist, including chronic plaque, guttate, pustular, inverse, and erythrodermic psoriasis. Lifestyle modification and topical therapies, such as emollients, coal tar, topical corticosteroids, vitamin D analogues, and calcineurin inhibitors, are used for limited disease. More severe psoriasis may require systemic therapy with oral or biologic therapy. Individualized management of psoriasis may involve different combinations of treatments. Counseling patients about associated comorbidities is essential.
科研通智能强力驱动
Strongly Powered by AbleSci AI